Outset Medical, Inc.
OM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.52 | -0.45 | -7.51 |
| FCF Yield | -203.27% | -50.25% | -12.39% | -6.35% |
| EV / EBITDA | -1.38 | -2.18 | -8.33 | -15.67 |
| Quality | ||||
| ROIC | -49.01% | -65.48% | -46.16% | -31.66% |
| Gross Margin | 33.92% | 22.24% | 15.46% | 7.42% |
| Cash Conversion Ratio | 0.91 | 0.76 | 0.89 | 0.99 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.49% | 8.31% | 32.20% | 89.50% |
| Free Cash Flow Growth | 13.05% | 12.49% | -15.51% | -23.35% |
| Safety | ||||
| Net Debt / EBITDA | -0.80 | -0.44 | -0.20 | 1.16 |
| Interest Coverage | -4.75 | -13.39 | -45.15 | -76.10 |
| Efficiency | ||||
| Inventory Turnover | 1.27 | 2.06 | 1.89 | 2.42 |
| Cash Conversion Cycle | 384.13 | 248.55 | 279.17 | 234.86 |